JAMES H. JANDL, M.D.; ARNOLD A. LEAR, M.D.
The prevalence of macrocytic anemia in patients with chronic liver disease has suggested to many observers that liver damage disturbs hematopoiesis by altering the storage or the metabolism of one or more of the substances effective in the treatment of pernicious anemia.1-4 However, it has been observed that most cases of the macrocytic anemia of liver disease bear little resemblance to pernicious anemia morphologically, and generally do not respond to liver extract.5, 6 Moreover, extracts prepared from the livers of patients with the anemia of liver disease have been found to possess antipernicious anemia activity.7 Nevertheless, apparent hematologic responses to
Learn more about subscription options.
Register Now for a free account.
JANDL JH, LEAR AA. THE METABOLISM OF FOLIC ACID IN CIRRHOSIS(THE METABOLISM OF FOLIC ACID IN CIRRHOSIS*). Ann Intern Med. 1956;45:1027–1044. doi: 10.7326/0003-4819-45-6-1027
Download citation file:
Published: Ann Intern Med. 1956;45(6):1027-1044.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only